Bobak R. Azamian, President/CEO and Board Chair at Tarsus Pharmaceuticals, Inc. (TARS), sold 6,000 shares at $55.37 ($332K) on 2025-09-24, disclosed to the SEC on 2025-09-26.
Scheduled sale ($332k) by President/CEO and Board Chair under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TARS | SELL | 2026-06-22 | $615K | — | Filing → |
| TARS | SELL | 2026-03-19 | $2.4M | — | Filing → |
| TARS | SELL | 2025-12-30 | $944K | — | Filing → |